Caspofungin
Caspofungin is a pharmaceutical drug with 36 clinical trials. Currently 2 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 24 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
10
Mid Stage
16
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.7%
24 of 28 finished
14.3%
4 ended early
2
trials recruiting
36
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
PK/PD of Caspofungin in Children Severe Infection
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
Liver Transplant European Study Into the Prevention of Fungal Infection
Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins
Clinical Trials (36)
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
PK/PD of Caspofungin in Children Severe Infection
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
Liver Transplant European Study Into the Prevention of Fungal Infection
Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins
Pharmacokinetics of Caspofungin
Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis
Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates
Effects and Safety of Caspofungin and Corticosteroids in Pneumocystis Pneumonia in Non-HIV Patients
Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP
Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients
A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy
Pharmacokinetics/Pharmacodynamics (PK/PD) of Caspofungin in Intensive Care Unit (ICU) Patients. An Open Observational Study for Antifungal Treatment's Optimization
A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)
Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients
Effect of Weight and/or Obesity on Caspofungin Drug Concentrations
Optimal Dosage of Caspofungin in Critically Ill Patients
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 36